Mount Pleasant, SC 29464, US
Medical Devices & Equipment
www.avancen.com
Avancen MOD Corporation is in a race to reduce patient pain. One way is with the MOD, a patented device that puts the patient in charge of their care, reduces wasted time for nurses and improves healthcare efficiency.
Avancen MOD Corporation is incorporated in South Carolina. Our official corporate address is Mt. Pleasant, SC. Our engineering and production facilities are in Melbourne, Fl. Avancen is a stockholder corporation funded by its investors.
The MOD® (Medication on Demand) is a bedside device with enterprise software that provides the patient with pain medication when they need it as prescribed by their practitioner. But there is more. There is the information flow, critical data needed and in fact required in today’s healthcare world. Information is essential for the patient, caregiver, and administrator. The MOD® and its system answer what they need to know. Avancen is not in competition with other similar products. We have created several unique devices with supportive IT.
We know we can achieve significant profits by 2017, and our potential revenues can exceed $1 Billion in the U.S. and greater than $3 billion in the global healthcare market.
Medication on Demand (MOD®) device delivers as-needed oral pain medications to patients as prescribed when the patient needs it without waiting for a nurse to deliver the medication
FDA Class I approved
Wi-Fi programming with multiple benefits
Enterprise level software MODtrac™ allows complete tracking and analytics
Ned Buffington has served as chief executive officer since 2009. He oversees all operations of the corporation. He has personally directed the medical and engineering staff in the innovation phase of the MOD and the proprietary software. The Medication on Demand (MOD®) device delivers as-needed oral pain medications to patients as prescribed when the patient needs it without waiting for a nurse to deliver the medication in healthcare facilities. In less than one year, the device has been ordered by over a dozen healthcare systems including Harvard’s Beth Isreal, the University of Pittsburgh, Tampa General and the Northport Health Services/Senior Care Pharmacy.
Sharon Conley, MD/PhD, Chief Medical Officer, Chief Regulatory Officer and MOD® Inventor: PhD in biochemistry and bench research; MD, internal medicine, oncology and pain management educator. Fellow, Curie Institute, Paris. Practiced more than 13 years prior to conceiving and contributing to the development of the MOD®
William (Bill) Westin, BS, MBA, Chief Financial Officer: Over 35 years in multiple financial positions in industries and companies from startup to $5 billion in assets.
Paul Pritchard, BA, MSP, Chief Operating Officer: Past Director of Marketing, Phillips Pharmaceuticals, CEO for over 25 years of national charities; writer, and publisher.